In light of prior studies that have illustrated the potential interplay between hyperammonemia and inflammation as a key factor in the development of MHE [17,18], our objective was to explore the impact of hyperammonemia and heightened inflammation on plasma NfL levels in MHE patients. The gene discussed is NEFL; the disease is Hyperammonemia.